Technical Report | Published:

A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse

Nature Biotechnology volume 21, pages 562565 (2003) | Download Citation



Functional redundancies, compensatory mechanisms, and lethal phenotypes often prevent the full analysis of gene functions through generation of germline null mutations in the mouse1. The use of site-specific recombinases, such as Cre, which catalyzes recombination between loxP sites2, has allowed the engineering of mice harboring targeted somatic mutations, which are both temporally controlled and cell-type restricted1,3. Many Cre-expressing mouse lines exist, but only a few transgenic lines are available that harbor a reporter gene whose expression is dependent on a Cre-mediated event3. Moreover, their use to monitor gene ablation at the level of individual cells is often limited, as in some tissues the reporter gene may be silenced1, be affected by position-effect variegation4, or reside in a chromatin configuration inaccessible for recombination5. Thus, one cannot validly extrapolate from the expression of a reporter transgene to an identical ablation pattern for the conditional allele of a given gene. By combining the ability of Cre recombinase to invert or excise a DNA fragment, depending on the orientation of the flanking loxP sites6, and the availability of both wild-type (WT) and mutant loxP sites7, we designed a Cre-dependent genetic switch (FLEx switch) through which the expression of a given gene is turned off, while the expression of another one is concomitantly turned on. We demonstrate the efficiency and reliability of this switch to readily detect, in the mouse, at the single cell level, Cre-mediated gene ablation. We discuss how this strategy can be used to generate genetic modifications in a conditional manner.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    & Site- and time-specific gene targeting in the mouse. Methods 24, 71–80 (2001).

  2. 2.

    & Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc. Natl. Acad. Sci. USA 85, 5166–5170 (1988).

  3. 3.

    Cre recombinase: the universal reagent for genome tailoring. Genesis 26, 99–109 (2000).

  4. 4.

    , & Variegation associated with lacZ in transgenic animals: a warning note. Transgenic Res. 9, 237–239 (2000).

  5. 5.

    , & A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent. EMBO Rep. 2, 292–297 (2001).

  6. 6.

    , & Studies on the properties of P1 site-specific recombination: evidence for topologically unlinked products following recombination. Cell 32, 1301–1311 (1983).

  7. 7.

    , & Using an in vivo phagemid system to identify non-compatible loxP sequences. FEBS Lett. 499, 147–153 (2001).

  8. 8.

    , & Formation of small circular DNA molecules via an in vitro site-specific recombination system. Gene 40, 325–329 (1985).

  9. 9.

    et al. Comparative kinetic analysis of FLP and cre recombinases: mathematical models for DNA binding and recombination. J. Mol. Biol. 284, 363–384 (1998).

  10. 10.

    et al. A conditional floxed (loxP-flanked) allele for the retinoic acid receptor gamma (RARγ) gene. Genesis 32, 95–98 (2002).

  11. 11.

    et al. Function of retinoic acid receptor gamma in the mouse. Cell 73, 643–658 (1993).

  12. 12.

    , & Recombinase mediated gene activation and site-specific integration in mammalian cells. Science 251, 1351–1355 (1991).

  13. 13.

    , , , & A β-galactosidase hybrid protein targeted to nuclei as a marker for developmental studies. Proc. Natl. Acad. Sci. USA 84, 6795–6799 (1987).

  14. 14.

    et al. RXR-α ablation in skin keratinocytes results in alopecia and epidermal alterations. Development 128, 675–688 (2000).

  15. 15.

    & Role of nucleotide sequences of loxP spacer region in Cre-mediated recombination. Gene 216, 55–65 (1998).

  16. 16.

    Selection-marker-free modification of the murine β-casein gene using a lox2272 [correction of lox2722] site. Anal. Biochem. 290, 260–271 (2001).

  17. 17.

    et al. Altered directionality in the Cre-LoxP site-specific recombination pathway. J. Mol. Biol. 311, 453–459 (2001).

  18. 18.

    et al. Endothelium-specific replacement of the connexin 43 coding region by a lacZ reporter gene. Genesis 29, 1–13 (2001).

  19. 19.

    et al. Site-specific chromosomal integration in mammalian cells: highly efficient Cre recombinase-mediated cassette exchange. J. Mol. Biol. 292, 779–785 (1999).

  20. 20.

    , & A simple assay to determine the functionality of Cre or FLP recombination targets in genomic manipulation constructs. Nucleic Acids Res. 24, 3118–3119 (1996).

Download references


We thank B. Féret, G. Kimmich, and E. Blondelle for technical assistance, J.M. Garnier, A. Dierich, and M. Mark for their active contribution to this work, and G. Richards for critical reading of the manuscript. We also thank M. Li for K14-Cre mice and J.F. Nicolas for the lacZ gene. This work was supported by funds from the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Santé et de la Recherche Médicale (INSERM), the Université Louis Pasteur (ULP), the Hôpital Universitaire de Strasbourg, the Collège de France, and the Association pour la Recherche sur le Cancer (ARC). F.S. was supported by a Marie Curie Fellowship from the European Community and C.C. by the Institut National de la Recherche Agronomique (INRA).

Author information

Author notes

    • Frank Schnütgen

    Present address: Molekulare Hämatologie, Theodor Stern Kai 7, Klinikum der Universität Frankfurt, 60590 Frankfurt am Main, Germany.


  1. Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, Collège de France, BP10142, 67404 Illkirch Ce dex, CU de Strasbourg, France.

    • Frank Schnütgen
    • , Nathalie Doerflinger
    • , Cécile Calléja
    • , Olivia Wendling
    • , Pierre Chambon
    •  & Norbert B. Ghyselinck


  1. Search for Frank Schnütgen in:

  2. Search for Nathalie Doerflinger in:

  3. Search for Cécile Calléja in:

  4. Search for Olivia Wendling in:

  5. Search for Pierre Chambon in:

  6. Search for Norbert B. Ghyselinck in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Norbert B. Ghyselinck.

Supplementary information

About this article

Publication history





Further reading